- January 26, 2025
- Posted by: admin
- Category: Uncategorized
No Comments
On January 31, 2025, at the IP-cure-B Strategic Meeting, ELPA Director Milan Mishkovikj showcased ELPA’s exceptional contributions and the bold vision ahead. Together with our world-class partners, we are reshaping the future of HBV treatment—driving innovation, advancing new therapies, and moving closer to a cure.
More on IP-cureB here. https://ipcureb.eu/